Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM)
    Meeting Abstract

    Hellmann, M. D.; Borsu, L.; Zehir, A.; Cheng, D. T.; Zha, Z.; Siegel, B.; Rohrer, R. W.; Robson, M. E.; Arnold, A. G.; Fleischut, M. H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics and prognostic impact of MET receptor overexpression in patients with stage I-IIIA squamous cell lung carcinomas (SQCLCs)
    Meeting Abstract

    Hellmann, M. D.; Anderson, T. A.; Eng, J.; Sima, C. S.; Kris, M. G.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • COMMAND: A phase II randomized, double-blind, placebo-controlled, multicenter study of defactinib as maintenance therapy in subjects with malignant pleural mesothelioma that has not progressed on at least four cycles of pemetrexed/platinum therapy
    Meeting Abstract

    Fennell, D. A.; Baas, P.; Kindler, H. L.; Krug, L. M.; Nowak, A.; Zauderer, M.; Gralla, R. J.; Keegan, M.; Horobin, J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Next steps for IBM Watson Oncology: Scalability to additional malignancies
    Meeting Abstract

    Epstein, A. S.; Zauderer, M. G.; Gucalp, A.; Seidman, A. D.; Caroline, A.; Fu, J.; Keesing, J.; Hsiao, F.; Megerian, M.; Eggebraaten, T.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas
    Meeting Abstract

    Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers
    Meeting Abstract

    Drilon, A. E.; Hellmann, M. D.; Wang, L.; Cho, E. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history
    Meeting Abstract

    Drilon, A. E.; Wang, L.; Arcila, M. E.; Cho, E. J.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Multi-institutional multiplexed genetic analysis in lung adenocarcinoma (AC): The Lung Cancer Mutation Consortium (LCMC I) experience
    Meeting Abstract

    Aisner, D.; Sholl, L. M.; Varella-Garcia, M.; Berry, L. D.; Dias-Santagata, D.; Wistuba, I. I.; Chen, H.; Fujimoto, J.; Kugler, K.; Franklin, W. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Emerging science and therapies in non-small-cell lung cancer: Targeting the MET pathway
    Journal Article

    Kris, M. G.; Arenberg, D. A.; Herbst, R. S.; Riely, G. J.
    Clinical Lung Cancer (2014)

    Fulltext@MSK | Save
  • E12 and E47 are essential for TWIST1 dependent suppression of oncogene-induced senescence in NSCLC
    Meeting Abstract

    Mazzacurati, L.; Chatley, S. N.; Yochum, Z.; Rudin, C. M.; Tran, P. T.; Burns, T. F.
    Cancer Research (2014)

    Fulltext@MSK | Save